M
Mario Boccadoro
Researcher at University of Turin
Publications - 670
Citations - 39049
Mario Boccadoro is an academic researcher from University of Turin. The author has contributed to research in topics: Multiple myeloma & Lenalidomide. The author has an hindex of 83, co-authored 638 publications receiving 34589 citations. Previous affiliations of Mario Boccadoro include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Treatment of multiple myeloma: a randomized study of three different regimens.
M Tribalto,Sergio Amadori,Maria Cantonetti,A Franchi,Giuseppe Papa,Alessandro Pileri,Mario Boccadoro,F. Dammacco,Angelo Vacca,Riccardo Centurioni +9 more
TL;DR: The authors conclude that the inclusion of Vintristine in a combination chemotherapy does not produce clear survival benefits; a longer induction period (12 cycles) could allow a better differentiation between MP and VMCP regimens.
Journal ArticleDOI
Retinoic acid inhibits the growth of human myeloma cells in vitro.
Antonio Palumbo,Silvano Battaglio,Patrizia Napoli,Benedetto Bruno,Paola Omedè,Mario Boccadoro,Alessandro Pileri +6 more
TL;DR: The inhibitory effect of cRA was significantly superior to tRA (P= 0.0129) and IFN‐α, similar to IFN-γ and DEX, and the combination cRA + DEX markedly increased the effect of both cRA andDEX used as single agents.
Journal ArticleDOI
Erratum: Myeloma management guidelines: A consensus report from the scientific advisors of the international myeloma foundation (The Hematology Journal (2003) vol, 4 (379-398) 10.1038/sj.thj.6200312)
Brian G.M. Durie,Robert A. Kyle,Andrew R. Belch,William I. Bensinger,Joan Bladé,Mario Boccadoro,J. Anthony Child,Raymond L. Comenzo,Ben Djulbegovic,Dorotea Fantl,Gösta Gahrton,Jean Luc Harousseau,Vania Hungria,Douglas E. Joshua,Heinz Ludwig,Jayesh Mehta,Angelina Rodrique Morales,Gareth J. Morgan,Amara Nouel,Martin M. Oken,R. L. Powles,David Roodman,Jesús F. San Miguel,Kazuyuki Shimizu,Seema Singhal,Bhawna Sirohi,Pieter Sonneveld,Guido Tricot,Brian G Van Ness +28 more
Journal ArticleDOI
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma.
Lisa Bonello,Claudia Voena,Marco Ladetto,Mario Boccadoro,Giorgio Palestro,Giorgio Inghirami,Roberto Chiarle +6 more
TL;DR: Down regulation of cell adhesion molecules LFA-l and ICAM-l after in vitro treatment with the anti TNF alpha agent thalidomide and the results confirmed the importance of knowing the carrier and removal status of canine coronavirus.
Journal ArticleDOI
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation
Annamaria Brioli,Giulia Perrone,Francesca Patriarca,Annalisa Pezzi,Francesco Nobile,Filippo Ballerini,Marina Motta,Sonia Ronconi,Paola Tacchetti,Lucio Catalano,Beatrice Anna Zannetti,Simonetta Rizzi,Sara Volpe,Elena Zamagni,Anna Marina Liberati,Katia Mancuso,Mario Boccadoro,Faith E. Davies,Gareth J. Morgan,Angela Palumbo,Michele Cavo +20 more
TL;DR: The number of collected PBSCs predicted better outcomes after auto-SCT and VTD overcame the negative impact of a poor stem cell mobilization, and differences were retained across patients randomized to the TD arm.